LCLA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Kalbe Farma Tbk PT

Watchlist Manager

Watchlist

Price: 0.039 EUR 2.63% Market Closed

Market Cap: €1.8B

K	Kalbe Farma Tbk PT XMUN:LCLA	ID
C	Conocophillips XMUN:YCP	US
D	Dream Residential Real Estate Investment Trust OTC:DRREF	CA
C	CSE Global Ltd F:XCC	SG

Profitability Summary

Kalbe Farma Tbk PT's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

38%

Sustainable 3Y Average Gross Margin

38%

Declining Gross Margin

39% > 38%

Healthy Operating Margin

13%

Sustainable 3Y Average Operating Margin

12%

Declining Operating Margin

14% > 13%

Healthy Net Margin

10%

Low 3Y Average Net Margin

10%

Declining Net Margin

11% > 10%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

2% > 7%

Positive ROE

15%

Positive 3Y Average ROE

Positive 3Y Average ROIC

14%

Declining ROIC

16% > 15%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.